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Abstract
House dust mite allergen is thought to be a major cause of asthma. Characterization of these allergen molecules is therefore
an important step for the development of effective diagnostic and therapeutic agents against mite-associated allergic
disorders. Here we report molecular cloning and expression of the group 6 (chymotrypsin-like) allergen from the house dust
mite, Dermatophagoides farinae. Sequencing analysis indicates that cloned cDNA, designated Der f 6, encodes a 279 amino
acid polypeptide which conserves a primary structure characteristic for chymotrypsin-like serine proteases found in
mammals. Recombinant Der f 6 expressed in Escherichia coli bound IgE in a pool made of 20 sera, and induced histamine
release from patients’ peripheral blood cells. ß 1999 Elsevier Science B.V. All rights reserved.
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Allergens from the house dust mites, Dermatopha-
goides farinae and Dermatophagoides pteronyssinus,
are major causes of allergic disorders such as bron-
chial asthma, atopic dermatitis, and allergic rhinitis
[1,2]. Identi¢cation and characterization of important
mite allergens have been done in the last decade via
immunochemical, biochemical and molecular biolog-
ical techniques, and ten major mite allergens are now
classi¢ed. The group 1 (cysteine protease) and 2 mite
allergens are important [3^9], and the groups 5, 7,
and 8 (glutathione S-transferase) are also thought to
be major allergens [10^12]. Our group have cloned
several cDNAs encoding additional important mite
allergens, including the group 10 (tropomyosin), Mag
29 (heat shock protein 70-like molecule), Mag 1
(39 kDa allergen), and Mag 3 [13^16].
Numerous allergens have proteolytic activities that
may contribute to their allergenicity. In the case of
allergic bronchial asthma, proteolytic mite allergens
are involved in the enhancement of airway in£amma-
tion and hyperresponsiveness by accelerating vascu-
lar permeability or non-IgE-mediated mast cell de-
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granulation [17,18]. In addition to the group 1 aller-
gen, serine proteases in the house dust mite are also
recognized as highly immunogenic proteolytic aller-
gens, and are comprised of group 3 (trypsin), group 6
(chymotrypsin), and group 9 (collagenase) allergens
[19^24]. Recent evidence has indicated novel roles of
these serine protease mite allergens in the develop-
ment of allergic disorders besides their IgE-binding
ability. Maruo et al. [25] have reported that Der 3
members activate the complement system to produce
anaphylatoxins. Moreover, King et al. [26] have re-
vealed that Der p 9 triggers the secretion of proin-
£ammatory cytokines from human bronchial epithe-
lium. This evidence suggests a possible involvement
of serine protease allergens in the pathogenesis of
allergic asthma. However, the detailed immunochem-
ical properties of serine protease mite allergens are
poorly understood. In this study, we carried out
cDNA cloning and Escherichia coli expression of
Der f 6, a new member of serine protease allergen
from the house dust mite, D. farinae.
To clone the group 6 mite allergen cDNA, we ¢rst
Fig. 1. Nucleotide and deduced amino acid sequences of Der f 6. The amino acid sequence is numbered sequentially from the ¢rst
amino acid of the putative zymogen. The sequence corresponding to the reported N-terminal Der f 6 polypeptide (Nos. 2^20 [23]) is
underlined, and the putative mature N-terminus (Val residue) is shown open boxed. The polyadenylation signal (AATAAA, Nos.
972^977) is also underlined.
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screened the D. farinae cDNA library (constructed in
VExcell vector, Amersham Pharmacia Biotech, Upp-
sala, Sweden) with rabbit antiserum raised against
puri¢ed natural Der f 6 protein, and isolated a pos-
itive cDNA clone (mag132). Insert cDNA was then
subcloned into pUC-19 vector (Takara, Kyoto, Ja-
pan), and both strands of the cDNA were sequenced
as described [16]. Initial sequencing analysis indi-
cated that the mag132 clone did not contain the
ATG start codon (the mag132 cDNA consisted of
909 nucleotides; Nos. 110^1018 in Fig. 1). To clone
full-length Der f 6 cDNA, the rapid ampli¢cation
protocol for cDNA end (RACE)-PCR was per-
formed. As a forward primer, the VExcell vector se-
Fig. 2. (A) Amino acid sequence comparison of Der f 6 with another group 6 dust mite allergen Der p 6 [24]. Identical amino acid
residues are shown open boxed. (B) Multiple sequence alignment of Der f 6, Der p 6, and chymotrypsinogens from human [29] and
bovine [30]. Identical amino acids within four polypeptides are shown open boxed. Conserved cysteine residues (Nos. 30, 46, 155, 171,
180, and 206) are in bold letters and shown gray boxed. The amino acids that comprise the catalytic triad (His-45, Asp-91, and Ser-
184; indicated by ‘*’) and the substrate recognition site (Ser-178; indicated by ‘a’) are also in bold and gray boxed.
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quence (CGCCAAGCTATTTAGGTGAC, nucleo-
tide sequence Nos. 2064^2083) was used. A reverse
primer corresponding to the 5P-Der f 6 coding se-
quence was designed within nucleotide sequence
Nos. 147^168 (Fig. 1) as its complementary orienta-
tion (CATTTGAATCAAGATATGCCCA). The re-
sulting PCR fragment was subcloned into pGEM-T
vector (Promega, Madison, WI, USA), and then se-
quenced. Cloned 1018 bp cDNA, designated Der f 6,
contains an 840 bp open reading frame encoding a
279 amino acid polypeptide with a calculated molec-
ular mass of 30 534 Da (Fig. 1). Yasueda et al. [23]
have elucidated the partial N-terminal amino acid
sequence of natural Der f 6 as (A)(V) GGQDA-
DLAEAPFQISLLK. In the deduced amino acid
sequence, we ¢nd the same sequence as for the re-
ported N-terminal Der f 6 protein (VGGQDA-
DLAEAPFQISLLK, amino acids 2^20, shown
underlined in Fig. 1), con¢rming that the cDNA ac-
tually encodes Der f 6 protein. Since the initial amino
acid residue of the reported sequence (i.e. Ala resi-
due) has been tentatively assigned [23], it is likely
that the putative mature N-terminus of Der f 6 poly-
peptide is a Val residue (shown boxed in Fig. 1). The
calculated molecular mass of the mature Der f 6
polypeptide (25 034 Da, amino acids 1^230) roughly
coincided with that of its reported natural counter-
part (25 kDa).
Amino acid sequence comparison indicated that
the putative Der f 6 polypeptide showed signi¢cant
homology (75.1% identity) with another cloned chy-
motrypsin-like allergen Der p 6 (Fig. 2A) [24]. This
further con¢rms that our cDNA encodes a new
member of the group 6 family mite allergen. Hydro-
pathy plot analysis [27] indicated that the N-terminal
17 amino acid sequence of Der f 6, as well as 16 ami-
no acids of Der p 6, was highly hydrophobic (data
not shown), implicating that this portion may serve
as a signal peptide. The sequence proximal to the
proenzyme-cleavage site (Nos. 35 to 7, see Fig.
C
Fig. 3. (A) Expression and puri¢cation of r-Der f 6. Protein
samples were run on a 10% polyacrylamide gel, and visualized
by Coomassie brilliant blue staining. Lanes: M, molecular
weight standard; 1, total cell lysate of the E. coli transformant
(100 Wl culture); 2, precipitate of the cell lysate after sonication
(5 Wg); 3, puri¢ed GST-r-Der f 6 fusion protein (2 Wg);
4, thrombin digest of the fusion protein (5 Wg); 5, puri¢ed
r-Der f 6 via preparative SDS-PAGE (1 Wg). (B) Immunoblot-
ting analysis of r-Der f 6. GST-r-Der f 6 (2 Wg) or r-Der f 6
(1 Wg) were electronically transferred onto a PVDF ¢lter (Im-
mobilon P, Millipore, Bedford, MA, USA). After incubation
with a blocking bu¡er (3% skim milk, 0.05% Tween 20 in
PBS), the ¢lter was probed with primary rabbit anti-Der f 6 se-
rum (2000-fold dilution in the blocking bu¡er), followed by
staining with 1 Wg/ml secondary peroxidase-conjugated goat
anti-rabbit IgG antibody (Santa Cruz Biotechnology, Santa
Cruz, CA, USA) (left panel). To test IgE binding, the ¢lter was
incubated with diluted pooled sera from mite-allergic patients
(n = 20), and then incubated with 1 Wg/ml peroxidase-conjugated
goat anti-human IgE antibody (Zymed, San Francisco, CA,
USA) (right panel). Protein bands were visualized using the Im-
munostaining Kit (Konica, Tokyo, Japan).
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2A) was well conserved (91.7% identity) within Der
f 6 and Der p 6. BLAST amino acid similarity
searching [28] indicated that the Der f 6 sequence
also exhibited homology (30^40%) with serine pro-
teases (trypsin, chymotrypsin, elastase, tryptase, etc.)
from various species. Especially, signi¢cant align-
ments were derived when compared with the group
3 trypsin-like mite allergen Der f 3 (36.1% [17]), Der
p 3 (37.2% [18]), or chymotrypsin from the African
malaria mosquito (37.2%, GenBank accession No.
Z18887). Multiple alignment of the deduced Der f 6
polypeptide sequence with those of reported chy-
motrypsins (Der p 6 [24], human and bovine chymo-
trypsinogens [29,30]) indicated that six cysteine resi-
dues (amino acids 30, 46, 155, 171, 180, and 206),
which have been demonstrated to form three disul-
¢de bonds in bovine chymotrypsinogen [31], are con-
served in Der f 6 (shown boxed and shaded in Fig.
2B). Moreover, we found that amino acid residues
participating to form the chymotrypsin-characteristic
substrate recognition site (Ser-178; indicated by an
open circle) and the typical catalytic triad (His-45,
Asp-91, and Ser-184; indicated by asterisks) of the
serine protease family are also conserved in Der f 6
(Fig. 2B). These data indicate that the putative
Der f 6 polypeptide possesses a primary structure
characteristic for the chymotrypsin family serine pro-
tease.
We next constructed an expression system of re-
combinant Der f 6 (r-Der f 6) in E. coli. Der f 6
cDNA fragment (nucleotides 110^1018, correspond-
ing to amino acids 333 to 230) carrying EcoRI-NotI
adaptors (Amersham Pharmacia Biotech) was
cleaved from VExcell vector by EcoRI digestion,
and then cloned into the glutathione S-transferase
(GST)-tagged pGEX-4T-3 vector (Amersham Phar-
macia Biotech). When using this construct, ¢ve extra
amino acids from the EcoRI-NotI adaptor sequence
(NSRPL) should be added at the Val residue (amino
acids 333 in Fig. 1) of r-Der f 6. The transformant
was cultured in 2UYT medium (2 l) supplemented
with 0.1% IPTG to express r-Der f 6 as a GST-fusion
protein. SDS-PAGE analysis indicated that a pre-
dicted 57 kDa protein was newly detected in the total
cell lysate (Fig. 3A, lane 1) and the insoluble precip-
itate of cell lysate after sonication (lane 2). Puri¢ca-
tion using preparative SDS-PAGE [16], we obtained
5 mg of the 57 kDa GST-fusion protein (lane 3).
After dialysis against PBS for removing SDS, the
fusion protein was subsequently digested with throm-
bin (10 units/mg protein) to remove the GST tag.
Thrombin digestion resulted in four protein frag-
Fig. 4. Puri¢ed r-Der f 6 possesses histamine release activity. Peripheral blood cells from mite-allergic patients were suspended in
Hanks’ bu¡er, and stimulated with a series of diluted antigens at 37‡C for 30 min. Released histamine in the supernatant was ana-
lyzed on a HPLC system (Hitachi, Tokyo, Japan) as described [33]. Total or control histamine release was determined using samples
from perchloric acid lysis of cell aliquots and cells incubated in Hanks’ bu¡er, respectively. We preliminary con¢rmed speci¢city of
the reaction using crude mite antigen and non-speci¢c sea squirt protein as positive and negative controls (data not shown). Only the
three histamine release-positive cases (among six patients tested) are indicated.
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ments (31 kDa, 30 kDa, 26 kDa, and 24 kDa, indi-
cated in lane 4). The 26 kDa fragment was the GST
tag, since only this molecule was recognized by rab-
bit anti-GST serum (data not shown). The other
three fragments (i.e. 31 kDa, 30 kDa, and 24 kDa
molecules) were shown to be derived from r-Der f 6,
as demonstrated by anti-Der f 6 immunoblot analysis
(data not shown). The 31 kDa fragment was likely to
be r-Der f 6. The 30 kDa fragment might have re-
sulted via internal thrombin digestion of r-Der f 6,
since two thrombin cleavage sites [32] are seen in the
Der f 6 sequence (RFPR/SL (Nos. 330 to 325) and
LQPK/WA (Nos. 325 to 320)) that potentially pro-
duce a 30 kDa fragment. The reason why the 24 kDa
fragment arises during the thrombin reaction is cur-
rently unknown. We puri¢ed the 31 kDa molecule
using a preparative SDS-PAGE, followed by dialysis
against PBS, for further immunochemical character-
ization (lane 5). The yield of the puri¢ed 31 kDa
fragment was 91.5 Wg protein. Immunoblotting anal-
ysis indicated that both the puri¢ed 57 kDa GST-
fusion protein and the 31 kDa protein were recog-
nized by rabbit anti-Der f 6 serum (left panel of Fig.
3B), con¢rming successful expression and puri¢ca-
tion of r-Der f 6.
To test whether our E. coli-produced r-Der f 6 has
IgE-binding ability, puri¢ed 31 kDa r-Der f 6 was
immunoblotted with diluted pooled serum IgE from
mite-allergic patients (n = 20). As shown in Fig. 3B
(right panel), 31 kDa r-Der f 6, as well as 57 kDa
GST-Der f 6, were shown to be recognized by the
patients’ IgE, indicating that the r-Der f 6 still retain
IgE-binding property even in denaturing condition.
This immunoblot assay also suggests that the pa-
tients’ IgE antibodies should recognize linear epito-
pes on the Der f 6 polypeptide. Scanning and iden-
ti¢cation of those linear epitopes is under
investigation. Our preliminary ELISA analyses using
sera from 38 mite-allergic patients (a patient group
which is 80% positive for IgE binding against major
mite allergen Der f 1) have indicated that IgE-bind-
ing frequency of recombinant Der f 6 was 39% (data
not shown), which is comparable to that of reported
natural Der f 6 (41% [23]). This suggests that our r-
Der f 6 might retain IgE-binding ability comparable
to that of natural Der f 6, although further exami-
nation is required for critical estimation of the IgE-
binding frequency by comparing its reactivity with
that of its natural counterpart.
Yasueda et al. have reported that natural Der f 6
exhibited skin test-positive phenotypes [23], implicat-
ing potent histamine release ability of Der f 6. To
test this possibility, we next examined whether r-Der
f 6 is able to induce histamine release from patients’
peripheral blood cells. In six patients tested, r-Der f
6-triggered histamine release was observed in three
cases (shown in Fig. 4), showing the ¢rst evidence
of histamine release activity of r-Der f 6. Signi¢-
cantly, patients A and B required a relatively low
antigen concentration (2^10 ng/ml) for triggering his-
tamine release, suggesting potent allergenicity of
r-Der f 6.
Here we elucidated the primary structure of the
group 6 house dust mite allergen Der f 6, and also
indicated that r-Der f 6 expressed in E. coli still re-
tains allergenicity. Our group has recently noticed
that Der 3/Der 6 family members are major compo-
nents of an immunotherapeutic vaccine prepared
from mite feces which is demonstrated to exhibit
an excellent clinical score against mite-allergic pa-
tients (data not shown). This implicates that serine
protease allergens might be candidates for a recombi-
nant vaccine for allergic asthma. Der f 6 cloned in
the present paper will facilitate to test this possibility,
as well as to elucidate the involvement of the serine
protease allergen in the development of house dust
mite-associated allergic disorders.
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